ZSNI-21
ZSNI-21 is a dual ADAM17/HDAC2 inhibitor with demonstrated anti-proliferative activity against Bel-7402 cells and anti-metastatic effects in HCC-LM3 cell models, supporting its use in vitro for hepatocellular carcinoma mechanism and therapy research.
Product Specifications
Field of Research
Epigenetics & Chromatin, Molecular Biology
Molecular Formula
C26H25N3O5
Molecular Weight
459.49
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog